Skip to main content
. 2014 Oct;94(4):1099–1142. doi: 10.1152/physrev.00034.2013

Fig. 6.

Fig. 6.

Summary of disease conditions where CGRP plays a role. CGRP can be targeted pharmacologically with either the use of a CGRP analog to increase CGRP levels or a CGRP antagonist to block the actions of CGRP. These approaches are shown against the conditions that may benefit. For some conditions, e.g., diabetes, it is not yet clear whether CGRP supplementation or CGRP inhibition would be the most beneficial approach.